05/28/2024 3:26 PM | HSU ERIC C (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 12:30 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 1:39 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 10:26 AM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 12:44 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 2:20 PM | InMed Pharmaceuticals (Issuer) MANCINI ALEXANDRA DIANE JANET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 2:20 PM | HSU ERIC C (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/05/2024 2:20 PM | HULL ANDREW (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 2:27 PM | InMed Pharmaceuticals (Issuer) Jagpal Netta (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/22/2024 12:38 PM | HULL ANDREW (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 1:58 PM | ADAMS ERIC A (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 1:28 PM | ARMISTICE CAPITAL, LLC (Filed by) InMed Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 11:34 AM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 1:33 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 1:12 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 12:04 PM | HULL ANDREW (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:04 PM | InMed Pharmaceuticals (Issuer) MANCINI ALEXANDRA DIANE JANET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:05 PM | Baldasare Bryan T (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:07 PM | ADAMS ERIC A (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:07 PM | HSU ERIC C (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:08 PM | Grove Janet P (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:08 PM | InMed Pharmaceuticals (Issuer) Tegge Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:09 PM | InMed Pharmaceuticals (Issuer) WOUDENBERG MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:09 PM | InMed Pharmaceuticals (Issuer) Lemerond Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 12:09 PM | InMed Pharmaceuticals (Issuer) Johnson Shane Aaron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:21 PM | InMed Pharmaceuticals (Filer)
| Form 10-K/A | |
12/06/2023 8:02 AM | InMed Pharmaceuticals (Issuer) WOUDENBERG MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 1:50 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 11:15 PM | InMed Pharmaceuticals (Filer)
| Form EFFECT | |
11/13/2023 4:05 PM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
11/08/2023 4:05 PM | InMed Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/02/2023 1:56 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/27/2023 6:16 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/27/2023 3:08 PM | InMed Pharmaceuticals (Filer)
| Form DEFA14A | |
10/24/2023 3:18 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 4:18 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 10:43 AM | InMed Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/29/2023 10:30 AM | InMed Pharmaceuticals (Filer)
| Form NT 10-K | |
09/25/2023 3:12 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 6:29 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/31/2023 4:22 PM | HSU ERIC C (Reporting) InMed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Are You Positioned For The New Energy Goldrush? (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
07/24/2023 3:26 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 1:18 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 3:28 PM | InMed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |